{"id":47836,"date":"2022-08-31T12:02:13","date_gmt":"2022-08-31T10:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/"},"modified":"2022-08-31T12:02:13","modified_gmt":"2022-08-31T10:02:13","slug":"global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/","title":{"rendered":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5601377\/global-dna-vaccines-market-2022-2027-by-product?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3mhm7&amp;utm_campaign=1743960+-+Global+DNA+Vaccines+Market+Report+2022-2027%3A+Rise+in+Prevalence+of+Cancer+and+Infectious+Diseases+in+Humans+and+Animals+Driving+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing at a CAGR of 6.24%.\n<\/p>\n<p>\n<strong>Market Segmentations<\/strong>\n<\/p>\n<p>\nThe Global DNA Vaccines Market is segmented based on Product Type, Type, End Userand Geography.\n<\/p>\n<ul>\n<li>\nBy <strong>Product Type,<\/strong> the market is classified into Oncept, West Nile-Innovator, and West Nile-Innovator.\n<\/li>\n<li>\nBy <strong>Type,<\/strong> the market is classified into Therapeutic Vaccines and Prophylactic Vaccines.\n<\/li>\n<li>\nBy <strong>End User,<\/strong> the market is classified into Veterinary Clinics, and Veterinary Hospitals.\n<\/li>\n<li>\nBy <strong>Geography, <\/strong>the market is classified into Americas, Europe, Middle-East &amp; Africa and Asia-Pacific.\n<\/li>\n<\/ul>\n<p>\n<strong>Company Profiles<\/strong>\n<\/p>\n<p>\nThe report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies&#8217; recent development and competitive scenario. Some of the companies covered in this report are AstraZeneca, Eli-Lilly (Novartis Animal Health), Bristol-Myers Squibb, Geovax Labs, Inovio Pharmaceuticals (Vgx Animal Health), Genexine, Viatris (Rottapharm Biotech), Gilead Sciences, Zoetis (Fort Dodge Animal Health), Johnson &amp; Johnson, Merck, Pfizer, Sanofi-Aventis, etc.\n<\/p>\n<p>\n<strong>Countries Studied<\/strong>\n<\/p>\n<ul>\n<li>\nAmerica (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)\n<\/li>\n<li>\nEurope (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)\n<\/li>\n<li>\nMiddle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)\n<\/li>\n<li>\nAsia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)\n<\/li>\n<\/ul>\n<p>\n<strong>Competitive Quadrant<\/strong>\n<\/p>\n<p>\nThe report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\n<\/p>\n<p>\n<strong>Ansoff Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nThe report presents a detailed Ansoff matrix analysis for the Global DNA Vaccines Market. Ansoff Matrix, also known as Product\/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.\n<\/li>\n<li>\nThe report analyses the Global DNA Vaccines Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.\n<\/li>\n<li>\nBased on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nRise in Prevalence of Cancer and Infectious Diseases in Humans and Animals\n<\/li>\n<li>\nIncrease in Demand for DNA Vaccines\n<\/li>\n<li>\nGrowth in Number of Antibiotic Resistant Pathogens\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nLack of Immunogenicity Associated with DNA Vaccines\n<\/li>\n<li>\nLimited Knowledge about the Effects Of DNA Vaccines On Humans\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nDevelopment Of Novel Vaccines Using DNA Technology\n<\/li>\n<li>\nHigh Growth Potential In Untapped Emerging Economies\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nLengthy Development and Approval Process\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Report Description<\/strong>\n<\/p>\n<p>\n<strong>2 Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong>5 Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>6 Global DNA Vaccines Market, By Product Type<\/strong>\n<\/p>\n<p>\n<strong>7 Global DNA Vaccines Market, By Type<\/strong>\n<\/p>\n<p>\n<strong>8 Global DNA Vaccines Market, By End User<\/strong>\n<\/p>\n<p>\n<strong>9 Americas&#8217; DNA Vaccines Market<\/strong>\n<\/p>\n<p>\n<strong>10 Europe&#8217;s DNA Vaccines Market<\/strong>\n<\/p>\n<p>\n<strong>11 Middle East and Africa&#8217;s DNA Vaccines Market<\/strong>\n<\/p>\n<p>\n<strong>12 APAC&#8217;s DNA Vaccines Market<\/strong>\n<\/p>\n<p>\n<strong>13 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>14 Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>15 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAstraZeneca\n<\/li>\n<li>\nEli-Lilly (Novartis Animal Health)\n<\/li>\n<li>\nBristol-Myers Squibb\n<\/li>\n<li>\nGeovax Labs\n<\/li>\n<li>\nInovio Pharmaceuticals (Vgx Animal Health)\n<\/li>\n<li>\nGenexine\n<\/li>\n<li>\nViatris (Rottapharm Biotech)\n<\/li>\n<li>\nGilead Sciences\n<\/li>\n<li>\nZoetis (Fort Dodge Animal Health)\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nMerck\n<\/li>\n<li>\nPfizer\n<\/li>\n<li>\nSanofi-Aventis\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5601377\/global-dna-vaccines-market-2022-2027-by-product?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=f3mhm7&amp;utm_campaign=1743960+-+Global+DNA+Vaccines+Market+Report+2022-2027%3A+Rise+in+Prevalence+of+Cancer+and+Infectious+Diseases+in+Humans+and+Animals+Driving+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/23jnwk<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;p&#114;&#x65;&#x73;s&#64;&#x72;e&#115;&#x65;&#x61;r&#99;&#x68;&#x61;n&#100;&#x6d;a&#114;&#x6b;&#x65;t&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#64;&#114;&#101;&#115;ear&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#97;&#114;&#107;ets&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47836","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-31T10:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-31T10:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/\"},\"wordCount\":706,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005428\\\/en\\\/1557918\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/\",\"name\":\"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005428\\\/en\\\/1557918\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-31T10:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005428\\\/en\\\/1557918\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220831005428\\\/en\\\/1557918\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-31T10:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-08-31T10:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/"},"wordCount":706,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/","name":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg","datePublished":"2022-08-31T10:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220831005428\/en\/1557918\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-dna-vaccines-market-report-2022-2027-rise-in-prevalence-of-cancer-and-infectious-diseases-in-humans-and-animals-driving-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47836"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47836\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}